Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Merck
US Army
Daiichi Sankyo
Fish and Richardson
McKesson
Covington
Cerilliant
QuintilesIMS
Federal Trade Commission

Generated: August 16, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040708

« Back to Dashboard
NDA 040708 describes LIDOCAINE HYDROCHLORIDE VISCOUS, which is a drug marketed by Vintage, Actavis Mid Atlantic, and Intl Medication, and is included in three NDAs. It is available from four suppliers. Additional details are available on the LIDOCAINE HYDROCHLORIDE VISCOUS profile page.

The generic ingredient in LIDOCAINE HYDROCHLORIDE VISCOUS is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.

Summary for NDA: 040708

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Anesthetics
Formulation / Manufacturing:see details

Pharmacology for NDA: 040708

Ingredient-typeAmides
Physiological EffectLocal Anesthesia

Suppliers and Packaging for NDA: 040708

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LIDOCAINE HYDROCHLORIDE VISCOUS
lidocaine hydrochloride
SOLUTION;ORAL 040708 ANDA Par Pharmaceutical 0603-1393 0603-1393-64 100 mL in 1 BOTTLE (0603-1393-64)
LIDOCAINE HYDROCHLORIDE VISCOUS
lidocaine hydrochloride
SOLUTION;ORAL 040708 ANDA Unit Dose Services 50436-1827 50436-1827-1 100 mL in 1 BOTTLE (50436-1827-1)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;ORALStrength2%
Approval Date:Feb 27, 2007TE:ATRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Julphar
Healthtrust
Cipla
Merck
Citi
Chinese Patent Office
Moodys
Queensland Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot